Fol. Biol. 2017, 63, 52-59
https://doi.org/10.14712/fb2017063020052
Downregulation of p68 RNA Helicase (DDX5) Activates a Survival Pathway Involving mTOR and MDM2 Signals
References
1. , P. T., Hay, N. (2007) The two TORCs and Akt. Dev. Cell 12, 487-502.
<https://doi.org/10.1016/j.devcel.2007.03.020>
2. , M., Guil, S., Kokolo, M., Bach-Elias, M. (2008) P68 RNA helicase (DDX5) alters activity of cis- and trans-acting factors of the alternative splicing of H-Ras. PLoS One 3, e2926.
<https://doi.org/10.1371/journal.pone.0002926>
3. , M., Kokolo, M., Heesom, K. J., Ladomery, M., Bach- Elias M. (2009) P19 H-ras induces G1/S phase delay maintaining cells in a reversible quiescence state. PLoS One 4, e8513.
<https://doi.org/10.1371/journal.pone.0008513>
4. , M., Hislop, R. G., Kernohan, N. M., Carey, F. A, Kay, R. A., Steele, R. J., Fuller-Pace, F. V. (2001). Overexpression and poly-ubiquitylation of the DEAD-box RNA helicase p68 in colorectal tumours. Oncogene 20, 7734-7743.
<https://doi.org/10.1038/sj.onc.1204976>
5. , E. L., Coulson, A., Dalgliesh, C., Rajan, P., Nicol, S. M., Fleming, S., Heer, R., Gaughan, L., Leung, H. Y., Elliott, D. J., Fuller-Pace, F. V., Robson, C. N. (2008) The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer. Cancer Res. 68, 7938-7946.
<https://doi.org/10.1158/0008-5472.CAN-08-0932>
6. , T. Y., Cao, L., Yang, Z. C., Li, Y. S., Tan, L., Ran, X. Z., Shi, C. M. (2014) P68 RNA helicase as a molecular target for cancer therapy. J. Exp. Clin. Cancer Res. 33, 64.
<https://doi.org/10.1186/s13046-014-0064-y>
7. , E., Polay Espinoza, M., Fattet, L., Germann, S., Lambert, M. P., Neil, H., Zonta, E., Mortada, H., Gratadou, L., Deygas, M., Chakrama, F. Z., Samaan, S., Desmet, F. O., Tranchevent, L. C., Dutertre, M., Rimokh, R., Bourgeois, C. F., Auboeuf, D. (2014) RNA helicases DDX5 and DDX17 dynamically orchestrate transcription, miRNA, and splicing programs in cell differentiation. Cell Rep. 7, 1900-1913.
<https://doi.org/10.1016/j.celrep.2014.05.010>
8. , R. S., Colleoni, G. W., Caballero, O. L., Yamamoto, M., Almeida, M. S., Andrade V. C., Chauffaille M. de L., Silva W. A. Jr., Begnami M. D., Soares, F. A., Simpson, A. J., Zago, M. A., Vettore, A. L. (2009) SAGE analysis highlights the importance of p53csv, ddx5, mapkapk2 and ranbp2 to multiple myeloma tumorigenesis. Cancer Lett. 278, 41-48.
<https://doi.org/10.1016/j.canlet.2008.12.022>
9. , D. J., Li, A. G., Wei, G., Li, H. H., Kertesz, N., Lesche R., Whale, A. D., Martinez-Diaz, H., Rozengurt, N., Cardiff, R. D., Liu, X., Wu, H. (2003) PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell 3, 117-130.
<https://doi.org/10.1016/S1535-6108(03)00021-7>
10. , F. V. (2013) The DEAD box proteins DDX5 (p68) and DDX17 (p72): multi-tasking transcriptional regulators. Biochim. Biophys. Acta 1829, 756-763.
<https://doi.org/10.1016/j.bbagrm.2013.03.004>
11. , S., de La Iglesia, N., Fernandez-Larrea, J., Cifuentes, D., Ferrer, J. C., Guinovart, J. J., Bach-Elias, M. (2003a) Alternative splicing of the human proto-oncogene c-H-ras renders a new Ras family protein that trafficks to cytoplasm and nucleus. Cancer Res. 63, 5178-5187.
12. , S., Gattoni, R., Carrascal, M., Abián, J., Stévenin, J., Bach-Elias, M. (2003b). Roles of hnRNP A1, SR proteins, and p68 helicase in c-H-ras alternative splicing regulation. Mol. Cell. Biol. 23, 2927-2941.
<https://doi.org/10.1128/MCB.23.8.2927-2941.2003>
13. , R. S., Nicol, S. M., Quinlan, P. R., Thompson, A. M.., Meek, D. W., Fuller-Pace, F. V. (2014) The RNA helicase/transcriptional co-regulator, p68 (DDX5), stimulates expression of oncogenic protein kinase, Polo-like kinase-1 (PLK1), and is associated with elevated PLK1 levels in human breast cancers. Cell Cycle 13, 1413-1423.
<https://doi.org/10.4161/cc.28415>
14. , P. (2003) Yeast RNA helicases of the DEAD-box family involved in translation initiation. Biol. Cell 95, 157-167.
<https://doi.org/10.1016/S0248-4900(03)00032-7>
15. , A., Park, Y., Miething, C., Wilkinson, J. E., Gillis, J, Lowe, S. W., Vakoc. C. R., Stillman, B. (2014) Acquired dependence of acute myeloid leukemia on the DEAD-box RNA helicase DDX5. Cell Rep. 7, 1887-1899.
<https://doi.org/10.1016/j.celrep.2014.05.019>
16. , A., Patane, S., Porras, A., Dono, R., Maina, F. (2007) Met acts on Mdm2 via mTOR to signal cell survival during development. Development 134, 1443-1451.
<https://doi.org/10.1242/dev.02820>
17. , S. M., Fuller-Pace, F. V. (2010) Analysis of the RNA helicase p68 (Ddx5) as a transcriptional regulator. Methods Mol. Biol. 587, 265-279.
<https://doi.org/10.1007/978-1-60327-355-8_19>
18. , S. M., Bray, S. E., Black, H. D., Lorimore, S. A., Wright, E. G., Lane, D. P., Meek, D. W., Coates, P. J, Fuller- Pace, F. V. (2013) The RNA helicase p68 (DDX5) is selectively required for the induction of p53-dependent p21 expression and cell-cycle arrest after DNA damage. Oncogene 32, 3461-3469.
<https://doi.org/10.1038/onc.2012.426>
19. , M., Khare, V., Guturi, K. K., Das, N., Ghosh, M. K. (2015) The DEAD box protein p68: a crucial regulator of AKT/FOXO3a signaling axis in oncogenesis. Oncogene 34, 5843-5856.
<https://doi.org/10.1038/onc.2015.42>
20. , M. (2010) Human DEAD-box protein 3 has multiple functions in gene regulation and cell cycle control and is a prime target for viral manipulation. Biochem. Pharmacol. 79, 297-306.
<https://doi.org/10.1016/j.bcp.2009.08.032>
21. , V., MacPherson, D., Sas, D., Lin, Y., Snow, B., Jang, Y., Benchimol, S., Mak, T. W. (2001) Regulation of PTEN transcription by p53. Mol. Cell 8, 317-325.
<https://doi.org/10.1016/S1097-2765(01)00323-9>
22. , H. I., Yamagata, K., Sugimoto, K., Iwamoto, T., Kato, S., Miyazono, K. (2009) Modulation of microRNA processing by p53. Nature 460, 529-533.
<https://doi.org/10.1038/nature08199>
23. , L. C., Pandolfi, P. P. (2003) PTEN and p53: who will get the upper hand? Cancer Cell 3, 97-99.
<https://doi.org/10.1016/S1535-6108(03)00022-9>
24. , I., Sawyers, C. L. (2002) The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat. Rev. Cancer 2, 489-501.
<https://doi.org/10.1038/nrc839>
25. , L., Lin, C., Liu, Z. R. (2005) Signaling to the DEAD box - regulation of DEAD-box p68 RNA helicase by protein phosphorylations. Cell Signal. 17, 1495-1504.
<https://doi.org/10.1016/j.cellsig.2005.03.008>
26. , L., Lin, C., Liu, Z. R. (2006) P68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing axin from β-catenin. Cell 127, 139-155.
<https://doi.org/10.1016/j.cell.2006.08.036>
27. , L., Lin, C., Zhao, S., Wang, H., Liu, Z. R. (2007) Phosphorylation of p68 RNA helicase plays a role in plateletderived growth factor-induced cell proliferation by up-regulating cyclin D1 and c-Myc expression. J. Biol. Chem. 282, 16811-16819.
<https://doi.org/10.1074/jbc.M610488200>
28. , E., Bittencourt, D., Samaan, S., Germann, S., Dutertre, M., Auboeuf, D. (2013) The RNA helicase DDX5/p68 is a key factor promoting c-fos expression at different levels from transcription to mRNA export. Nucleic Acids Res. 41, 554-564.
<https://doi.org/10.1093/nar/gks1046>
